Bilateral corneal infection as a complication of laser in situ keratomileusis.
Watanabe
H
H
Sato
S
S
Maeda
N
N
Inoue
Y
Y
Shimomura
Y
Y
Tano
Y
Y
D000293:Adolescent; D015377:Cilastatin / Q000627:therapeutic use; D003315:Cornea / Q000187:drug effects / Q000382:microbiology; D003316:Corneal Diseases / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D016039:Corneal Transplantation / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D015818:Eye Infections, Bacterial / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use; D007275:Injections, Intravenous; D053685:Laser Therapy / Q000009:adverse effects*; D008297:Male; D015242:Ofloxacin / Q000627:therapeutic use; D009824:Ointments; D009883:Ophthalmic Solutions; D011480:Protease Inhibitors / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D013211:Staphylococcus aureus / Q000302:isolation & purification
D009824:Ointments; D009883:Ophthalmic Solutions; D011480:Protease Inhibitors; D015377:Cilastatin; D015378:Imipenem; D015242:Ofloxacin